Sunday, July 16, 2023 3:37:45 PM
Using AI to find the next blockbuster drug
This week, AI chipmaker Nvidia placed their bet — investing $50M into AI drug discovery platform Recursion Pharmaceuticals (NASDAQ:RXRX) — sending its stock up 78%.
Drugmakers are already benefiting from using AI to discover new drugs. And in the process, AI is speeding up and reducing the cost of the long and expensive drug development process.
Between 2015 and 2022, the cumulative investment in AI drug development has risen from under $1B to $24.6B.
In the next decade, Morgan Stanley expects AI will help develop an additional 50 drugs with an extra $50B in sales.
Following Nvidia’s investment, other AI drug discovery platforms rose on the news, including Exscientia (NASDAQ:EXAI), AbCellera Biologics (NASDAQ:ABCL) and Relay Therapeutics (NASDAQ:RLAY).
Recursion has five drugs, and Exscientia has three drugs discovered with AI, which are already in human trials. And within the startup sector, AI drug discovery has quickly become one of the hottest markets for investment.
This week, AI chipmaker Nvidia placed their bet — investing $50M into AI drug discovery platform Recursion Pharmaceuticals (NASDAQ:RXRX) — sending its stock up 78%.
Drugmakers are already benefiting from using AI to discover new drugs. And in the process, AI is speeding up and reducing the cost of the long and expensive drug development process.
Between 2015 and 2022, the cumulative investment in AI drug development has risen from under $1B to $24.6B.
In the next decade, Morgan Stanley expects AI will help develop an additional 50 drugs with an extra $50B in sales.
Following Nvidia’s investment, other AI drug discovery platforms rose on the news, including Exscientia (NASDAQ:EXAI), AbCellera Biologics (NASDAQ:ABCL) and Relay Therapeutics (NASDAQ:RLAY).
Recursion has five drugs, and Exscientia has three drugs discovered with AI, which are already in human trials. And within the startup sector, AI drug discovery has quickly become one of the hottest markets for investment.
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent EXAI News
- Expert.ai Named to the RegTech100 for 2026 • PR Newswire (US) • 12/10/2025 11:30:00 AM
- Expert.ai Presents EIX-Customer Screening for Intelligent Adverse News Monitoring in the Financial Sector • PR Newswire (US) • 11/25/2025 01:30:00 PM
- Expert.ai Strengthens Its Offering for the Insurance Industry with Advanced AI Solutions • PR Newswire (US) • 10/14/2025 12:30:00 PM
- Expert.ai Recognized for AI Excellence for Insurance Solutions in Annual InsurTech100 List • PR Newswire (US) • 09/30/2025 12:30:00 PM
- Expert.ai and Springer Nature Partner to Transform Clinical Trials with AI-Driven Intelligence and Deep Domain Expertise • PR Newswire (US) • 09/16/2025 12:30:00 PM
- Expert.ai Launches Enhanced Solutions for Digital Information Services • PR Newswire (US) • 09/10/2025 02:30:00 PM
